See Full Document Text
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
DEPARTMENT OF PHARMACEUTICALS
LOK SABHA
UNSTARRED QUESTION No. 5626
TO BE ANSWERED ON THE 27TH MARCH 2026
Supply of Generic Medicines
5626. Shri Vishnu Datt Sharma:
Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:
(a) whether the Government is implementing the Pradhan Mantri Bhartiya Janaushadhi
Pariyojana (PMBJP) nationwide to ensure affordable generic medicines for poor households;
(b) whether Jan Aushadhi Kendras (JAKs) have been established and are fully functional in the
districts of Katni, Panna and town of Khajuraho in the Khajuraho Lok Sabha Constituency of
Madhya Pradesh;
(c) the number of Kendras, average monthly sales and stock-out instances reported during the
last year;
(d) the measures taken to ensure uninterrupted availability of essential medicines, especially for
chronic diseases and TB/NCD patients;
(e) whether the coverage/supply remains inadequate in the said districts, if so, the reasons
therefor along with the corrective actions taken in this regard; and
(f) the plan to expand PMBJP coverage, strengthen supply chains and create local employment
through Kendras in the said districts?
ANSWER
THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND
FERTILIZERS
(SMT. ANUPRIYA PATEL)
(a): The Government launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme to
make quality generic medicines available at affordable prices to all. Under the scheme,
dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened across the country to
provide medicines at rates that are about 50% to 80% cheaper than those of branded medicines.
As of 28.02.2026, a total of 18,646 Jan Aushadhi Kendras have been opened across the country
under the scheme.
(b): A total of 38 Jan Aushadhi Kendras (JAKs) are functional in the Khajuraho Lok Sabha
Constituency of Madhya Pradesh including 9 JAKs in Katni district, 4 JAKs in Panna district
and 25 JAKs in the Chhatarpur district. These Kendras are established and made functional
after obtaining initial approval from Pharmaceuticals and Medical Devices Bureau of India
(PMBI) and obtaining of requisite license from State Drug Licensing Authorities.(c): A total of 4142 Jan Aushadhi Kendras have been opened and total sales of Rs. 2022.47
Crore at MRP have been made, across the country during the last financial year i.e F.Y. 2024-
25.
No major incidents have been reported for stock-out during the last financial year.
(d) and (e): The product basket under the Pradhan Mantri Bhartiya Janaushadhi Pariyojna has
2,110 medicines and 315 surgicals, medical consumables and devices, covering all major
therapeutic groups, such as cardiovascular, anti-cancer, anti-diabetic, anti-infectives, anti-
allergic and gastro-intestinal medicines and nutraceuticals. Almost all generic medicines
included in the National List of Essential Medicines, except lab reagents and vaccines, are part
of the product basket.
Currently, more than 850 medicines for chronic diseases and NCD patients are available in the
PMBI product basket. For anti- tuberculosis (TB) medicines, TB Mukt Bharat Abhiyan was
launched in the year 2021 and registration of all TB patients was done under a separate
campaign by the Ministry of Health and Family Welfare with the aim of providing free
medicines. PMBI surveyed more than 100 JAKs and decided not to include anti-TB medicines
due to low demand and the free availability under the aforementioned campaign.
With a view to ensure accessibility and availability of medicines at JAKs, the following
measures are in place:
(i) An end-to-end information-technology-enabled supply chain system consisting
currently of five warehouses and 41 distributors across the country, is in place.
(ii) Since September 2024, stocking by Jan Aushadhi Kendras (JAKs) of 200 commonly
used medicines, consisting of the 100 top-selling medicines in the product basket and
100 fast-selling medicines in the market, is incentivised with JAK owners being
eligible to receive monthly incentive based on the stocks that they maintain of these
medicines.
(iii) In addition, with a view to ensure availability of commonly used products, 400 fast-
moving products are monitored regularly by the scheme implementing agency
{Pharmaceuticals and Medical Devices Bureau of India (PMBI)} and demand for the
same is forecasted on an ongoing basis. Further, steps have been taken to digitise the
forecasting method to augment the procurement process through automation.
(f): The Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme serves as a robust avenue for
self-employment, offering sustainable and consistent income while creating employment across
multiple levels.To expand the coverage of the scheme, the Government has set a target to
increase in the total number of JAKs opened across the country to 25,000 by end of March
2027.
The Government has adopted a franchise-like model for opening of JAKs by inviting online
applications from individual entrepreneurs, non-governmental organisations, societies, trusts,
firms, private companies, etc. Any individual having D. Pharma. or B. Pharma. qualification
either herself/himself or any individual or organisation who has employed a person with such
qualification as a pharmacist for obtaining drug licence from the State Licensing Authority
concerned is eligible to open a Jan Aushadhi Kendra. Online applications have been invited
from all districts of the country, including all districts of state of, Madhya Pradesh through the
website www.janaushadhi.gov.in.
*****